Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 436 AL 450

Cognitive Dysfunction in Cats: Update on Neuropathological and Behavioural Changes Plus Clinical Management

Sordo L, Gunn-Moore DA.

Vet Rec. 2021 Jan;188(1):e3. doi: 10.1002/vetr.3. Epub 2021 Jan 12.

Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ(1-)(40) injection in ovariectomized Alzheimer's disease model rats

Xie Y, Yan B, Hou M, Zhou M, Liu C, Sun M, He K, Fang C, Chen Y, Huang L.

Pharm Biol. 2021 Dec;59(1):1402-1414. doi: 10.1080/13880209.2021.1990353.

Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

Liu XY, Zhang N, Zhang SX, Xu P.

Eur J Neurosci. 2021 Nov;54(10):7749-7769. doi: 10.1111/ejn.15502. Epub 2021 Nov 7.

Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease

Flores-Clemente C, Nicolás-Vázquez MI, Mera Jiménez E, Hernández-Rodríguez M.

Biomolecules. 2021 Sep 26;11(10):1408. doi: 10.3390/biom11101408.

Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review

Teselink J, Bawa KK, Koo GK, Sankhe K, Liu CS, Rapoport M, Oh P, Marzolini S, Gallagher D, Swardfager W, Herrmann N, Lanctôt KL.

Ageing Res Rev. 2021 Dec;72:101499. doi: 10.1016/j.arr.2021.101499. Epub 2021 Oct 23.

Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial

Zhang J, Kuang X, Tang C, Xu N, Xiao S, Xiao L, Wang S, Dong Y, Lu L, Zhang L.

Medicine (Baltimore). 2021 Nov 19;100(46):e27686. doi: 10.1097/MD.0000000000027686.

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease

Liu CS, Herrmann N, Song BX, Ba J, Gallagher D, Oh PI, Marzolini S, Rajji TK, Charles J, Papneja P, Rapoport MJ, Andreazza AC, Vieira D, Kiss A, Lanctôt KL.

BMC Geriatr. 2021 Dec 4;21(1):677. doi: 10.1186/s12877-021-02636-6.

A Brief Comparative Look at Experimental Memory Editing Techniques for Cognitive Dysfunction

Poon CH, Tan SZK, Sheng V, Wang S, Aquili L, Lim LW.

Curr Alzheimer Res. 2021;18(10):841-848. doi: 10.2174/1567205018666211208142036.

Impact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer's disease

Sprugnoli G, Munsch F, Cappon D, Paciorek R, Macone J, Connor A, El Fakhri G, Salvador R, Ruffini G, Donohoe K, Shafi MM, Press D, Alsop DC, Pascual Leone A, Santarnecchi E.

Alzheimers Res Ther. 2021 Dec 20;13(1):203. doi: 10.1186/s13195-021-00922-4.

The Impact of Exercising in the Quality of Life of People with Dementia-Alzheimer's Disease

Dimities M, Xristina F, Theodora-Elesa K, Maria C.

Adv Exp Med Biol. 2021;1339:309-315. doi: 10.1007/978-3-030-78787-5_36.

Dementia research in 2020: moving forward despite the COVID-19 pandemic

Kivipelto M, Mangialasche F.

Lancet Neurol. 2021 Jan;20(1):3-5. doi: 10.1016/S1474-4422(20)30453-1.

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.

JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.

New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease

Guzman-Martinez L, Calfío C, Farias GA, Vilches C, Prieto R, Maccioni RB.

J Alzheimers Dis. 2021;82(s1):S51-S63. doi: 10.3233/JAD-201059.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias